C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/09 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01) C07K 14/705 (2006.01)
Patent
CA 2755342
The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 45, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include the above mentioned amino acid sequence with substitution deletion, or addition of one, two, or several amino acids sequences. The invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for diagnosing or treating cancer.
La présente invention porte sur des peptides isolés ou sur les fragments issus de SEQ ID NO: 45, qui se lient à un antigène HLA et induisent des lymphocytes T cytotoxiques (CTL). Les peptides peuvent comprendre la séquence d'acides aminés mentionnée ci-dessus avec substitution, délétion ou addition d'un, deux ou plusieurs séquences d'acides aminés. L'invention porte également des compositions pharmaceutiques comprenant ces peptides. Les peptides de la présente invention peuvent être utilisés pour le diagnostic ou le traitement du cancer.
Furukawa Yoichi
Nakamura Yusuke
Ohsawa Ryuji
Tsunoda Takuya
Watanabe Tomohisa
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Oncotherapy Science Inc.
LandOfFree
Neil3 peptides and vaccines including the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neil3 peptides and vaccines including the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neil3 peptides and vaccines including the same will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1841738